|
BIAF bioAffinity Technologies Inc 1712762 |
| Balance Sheet |
|
Current Assets
|
$4,341,401.00 |
|
Assets
|
$7,945,252.00 |
|
Current Liabilities
|
$3,184,960.00 |
|
Liabilities
|
$4,283,866.00 |
|
Equity
|
$3,661,386.00 |
|
Shares Out
|
4498675.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,227,240.00 |
|
Investing Cash Flow
|
$-5,663.00 |
| Market Analysis |
Market Cap
|
$2,879,152.00 |
|
Price
|
$0.61 |
|
BVPS
|
0.81 |
|
PB
|
0.79 |
|
EPS
|
-0.81 |
|
PS
|
0.69 |
|
FCF
|
$-3,232,903.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:48 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BIAF documents filed with the SEC.
BIAF Filings
Clear
